pioglitazone
111960
Approved small_molecule terminated
Quick answer
pioglitazone for Diabetes Mellitus, Type 2 is a Approved program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated